Influence of lavage timing on tumor cell burden during colonic resection

Diseases of the Colon and Rectum

Volumn 46, Issue 4, 2003, Pages 460-466

  Brundell, Simeon ^a   Tucker, Kirsty ^b   Chatterton, Barry ^b   Hewett, Peter ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Cancer; Colon; Laparoscopic; Lavage; Metastasis

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ANIMAL MODEL; ARTICLE; CELL COUNT; CELL VIABILITY; COLON LAVAGE; COLON RESECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; INOCULATION; INTESTINE ANASTOMOSIS; ISOTOPE LABELING; NONHUMAN; PERITONEAL CAVITY; RADIOACTIVITY; STAPLER; SWINE; TREATMENT OUTCOME; TUMOR CELL;

ANASTOMOSIS, SURGICAL; ANIMALS; COLECTOMY; COLON, SIGMOID; COLORECTAL NEOPLASMS; FEMALE; IRRIGATION; NEOPLASM SEEDING; SWINE; TUMOR CELLS, CULTURED;

EID: 0344406271     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-6583-4     Document Type: Article

References (15)

1. Goligher JC, Dukes CE, Bussey HJ. Local recurrences after sphincter-saving excisions for carcinoma of the rectum and rectosigmoid. Br J Surg 1951;39:199.
2. Umpleby HC, Fermor B, Symes MO, Williamson RC. Viability of exfoliated colorectal carcinoma cells. Br J Surg 1984;71:659-63.
3. Tsunoda A, Shibusawa M, Tsunoda Y, Kamiyama G, Yamazaki K, Kusano M. Effect of povidone-iodine on anastomotic tumor growth in an experimental model of colorectal cancer surgery. Anticancer Res 1999;19: 1149-52.
4. Docherty JG, McGregor JR, Purdie CA, Galloway DJ, O'Dwyer PJ. Efficacy of tumoricidal agents in vitro and in vivo. Br J Surg 1995;82:1050-2.
5. Hase K, Ueno H, Kuranaga N, Utsunomiya R, Ranabe S, Mochizuki H. Intraperitoneal exfoliated cancer cells in patients with colorectal cancer. Dis Colon Rectum 1998; 41:1134-40.
6. Ambrose NS, MacDonald F, Young J, Thompson H, Keighley MR. Monoclonal antibody and cytological detection of free malignant cells in the peritoneal cavity during resection of colorectal cancer - can monoclonal antibodies do better? Eur J Surg Oncol 1989;15:99-102.
7. Juhl H. Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal and pancreatic cancer patients. Int J Cancer 1994;57:330-5.
8. Skipper D, Jeffrey MJ, Cooper AJ, Alexander P, Taylor I. Enhanced growth of tumour cells in healing colonic anastomoses and laparotomy wounds. Int J Colorectal Dis 1989;4:172-7.
9. Umpleby HC, Williamson RC. The efficacy of agents employed to prevent anastomotic recurrence in colorectal carcinoma. Ann R Coll Surg Engl 1984;66:192-4.
10. Allardyce RA, Morreau P, Bagshaw PF. Operative factors affecting tumor cell distribution following laparoscopic colectomy in a porcine model. Dis Colon Rectum 1997;40:939-45.
11. Pandos G, Penglis S, Tsopelas C. Validation of a column method for technetium-99m exametazime quality control. J Nucl Med Technol 1999;27:306-8.
12. Iitska Y, Kaneshima S, Tanida O, Takeuchi T, Koga S. Intraperitoneal free cancer cells and their viability in gastric cancer. Cancer 1979;44:1476-80.
13. Hung JC, Chowdhury S, Mahoney DW, Mullan BP. Radiolabelled mixed leukocytes and pure granulocytes with stabilized 99Tcm-exametazime. Nucl Med Commun 1998;19:981-7.
14. Hung JC, Chowdhury S, Mullan BP. Use of stabilized technetium-99m-exametazime for radiolabeling leukocytes. J Nucl Med 1998;39:912-7.
15. Hansen E, Wolff N, Knuechel R, Ruschoff J, Hofstaedter F, Taeger K. Tumor cells in blood shed from the surgical field. Arch Surg 1995;130:387-93.